BreatheVision Overview
BreatheVision is an Israeli biotechnology start-up and the developer of SafeSed, a device designed for remote breathing monitoring. SafeSed is designed to accurately measure respiratory volume and patterns while also offering a device that is more cost effective and easily portable than those currently available. SafeSed uses a comprehensive set of variables to provide alerts in advance of adverse events in order to help prevent respiratory depression and respiratory compromise. SafeSed requires no wires or cables.
Cumulative Funding Raised Over Time ($)
$849KJun 2020
Latest News
growth-positive
https://www.jpost.com/health-science/coronavirus-israeli-start-up-aims-to-save-lives-by-tracking-breath-rate-628357
Israeli start-up BreatheVision has developed a technology that remotely monitors patients breath, minimizing the exposure of medical staff to infectious diseases. The system uses triangular markers placed on the patients chest and abdomen to monitor respiratory rate and depth of breathing. The markers have a Bluetooth connection and transmit data to a tablet, computer, or smartphone. BreatheVision is currently focusing on COVID-19 patients and those recovering from surgery under anesthesia. The company will start a pilot program with Sourasky Medical Centers Ichilov Hospital in Tel Aviv and plans to launch two more pilots in the United States. BreatheVision has received grants from the Israel Innovation Authority.
CustomersPartners
growth-positive
New device makes going under sedation safer
Israeli startup BreatheVision has developed a new solution for monitoring patients breathing during surgery. The SafeSed system combines wearables and optics to provide continuous monitoring of breathing volume, addressing a gap in existing medical devices. The system includes EEG-like patches and a belt worn by the patient, as well as a camera that tracks infrared emitters. SafeSed also includes an alarm system to alert surgical staff of any breathing problems. The technology is significantly cheaper than other options on the market, with a price of less than $700 per unit. BreatheVision has identified the hospital gastroenterology department as its initial target market.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $849K |
| Last funding | $849K |
| Stage | Seed |
| Rounds | 2 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | breathevision.com |
Locations
Kibbutz Yad Mordekhai, Israel
Photos & Videos
4 item(s)
BreatheVision Business
Business models
B2B
Product stage
Clinical Trial
Employees
1-10
Sector
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote MonitoringTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
Artificial IntelligenceTags (16)
medical-technologiesmedical-devicesremote-monitoringartificial-intelligencehealthcare-providersdiagnosticshome-caredata-analyticsdigital-healthcaredoctorshospitalsnon-invasiveclinicsrespiratorywearablesensorsGeographic Markets
GlobalBreatheVision Financials
$849K
Total funding
Undisclosed
Capital raised
$849K
Last funding
Seed
Funding stage
2
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$849KJun 2020
Private Equity Funding
Equity crowdfunding
Jun 2020
$849K
PipelBiz
Non-Equity Funding
GrantEvent
Sep 2015
Undisclosed
Office of the Chief Scientist
BreatheVision Lifecycle
Cumulative Funding Raised Over Time
$849KJun 2020
All Events
Equity crowdfunding
Jun 2020
$849K
PipelBiz
GrantEvent
Sep 2015
Undisclosed
Office of the Chief Scientist
BreatheVision News
2 articles
growth-positive
https://www.jpost.com/health-science/coronavirus-israeli-start-up-aims-to-save-lives-by-tracking-breath-rate-628357
Israeli start-up BreatheVision has developed a technology that remotely monitors patients breath, minimizing the exposure of medical staff to infectious diseases. The system uses triangular markers placed on the patients chest and abdomen to monitor respiratory rate and depth of breathing. The markers have a Bluetooth connection and transmit data to a tablet, computer, or smartphone. BreatheVision is currently focusing on COVID-19 patients and those recovering from surgery under anesthesia. The company will start a pilot program with Sourasky Medical Centers Ichilov Hospital in Tel Aviv and plans to launch two more pilots in the United States. BreatheVision has received grants from the Israel Innovation Authority.
CustomersPartners
growth-positive
New device makes going under sedation safer
Israeli startup BreatheVision has developed a new solution for monitoring patients breathing during surgery. The SafeSed system combines wearables and optics to provide continuous monitoring of breathing volume, addressing a gap in existing medical devices. The system includes EEG-like patches and a belt worn by the patient, as well as a camera that tracks infrared emitters. SafeSed also includes an alarm system to alert surgical staff of any breathing problems. The technology is significantly cheaper than other options on the market, with a price of less than $700 per unit. BreatheVision has identified the hospital gastroenterology department as its initial target market.
Customers
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
BreatheVision Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Ayelet Beazley |
| Registrar ID | 514981935 |
| Crunchbase | breathevision |
| Phone | +97286720512 |
| Creator | Shmuel (Sam) Rausnitz |
| Creator email | shmuel.rausnitz@sncentral.org |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wain@gmail.com |
| Last update | 2020-11-19T00:00:00.000Z |
| Created | 2016-10-05T00:00:00.000Z |
| Claimed | Yes |